24 participants
Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-12-20
- Start Date:
- 2025-02-01
- Completion:
- 2027-02-28
Conditions
- Non-Small Cell Lung Cancer
- Immunotherapy
- Neoadjuvant Therapy
Interventions
- DRUG
No Results Yet